Company Overview

We are a science-based health care company improving patient care through neurotechnology

 

Medical Devices

  • Founded in 1996 as MIT/Harvard Medical School spinoff
  • Based near Boston, MA
  • Public since 2004. Listed on Nasdaq as "NURO"

Focused on Point-of-Care Nerve Testing

  • Created concept and market
  • Market leader - 10 years plus, 5 million nerves tested, 1.5 million patients
  • Premier R&D capability in the space, proprietary technology, Intellectual Property

Two Aspects to the Business

  • Emerging business in diabetes care
  • Established business in neurodiagnostics
      • Orthopedics (hand surgery), primarily diagnosis of carpal tunnel syndrome
      • General purpose nerve testing within primary care